The excretion of urinary androgen has been determined in 21 cases of prostatic cancer before and after therapy with diethylstilbestrol. A considerable reduction was observed, thus showing that the hormonal therapy had reached the main scope of diminishing the androgenic production of the organism.
Get full access to this article
View all access options for this article.
References
1.
BarenghiM., Estrogeni sintetici e cancro, Libr. Vinciana Ed., Milano, 1946.
2.
BirkeG., e PlantinL. O., Acta End., 15, 61, 1954.
3.
BirkeG., FranksonC., e PlantinL. O., Acta End., 17, 1954.
4.
BurtF. B., FinneyR. P., e ScottW. W., Cancer, 10, 825, 1957.
5.
DelostP., C. R. Soc. Biol., 147, 760, 1953.
6.
DorfmannR. I., e ShipleyR. A., Androgens, Willey e Sons Inc., New York, 1956.
7.
ElchleppJ.G., J. Morph., 91, 1, 1952.
8.
EmersonK., N. E. J. Med., 254, 252, 1956.
9.
HarrinsonJ. H., ThornG. W., e JenkinsD., N. E. J. Med., 248, 86, 1953.
10.
HugginsC. H., e HodgesC. V., Cancer Res., 1, 293, 1941.
11.
HunterJ., cit. BurrowsH., e HornigE., Estrogens and neoplasia, Blackwell Sci. publ., Oxford, 1952.
